Advertisement
Screener

Evome Medical Technologies, Inc. Revenue

Evome Medical Technologies, Inc. Revenue

Evome Medical Technologies, Inc. reported Revenue of CAD 62.63 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-16.

Discontinued › Income Statement › Revenue

us-gaap:Revenues · last filed 2024-04-16

  • Evome Medical Technologies, Inc. revenues for the quarter ending 2023-12-31 was 15.72M CAD, a 49.05% increase year-over-year.
  • Evome Medical Technologies, Inc. revenues for the quarter ending 2023-09-30 was 19.65M CAD, a 78.30% increase year-over-year.
  • Evome Medical Technologies, Inc. revenues for the quarter ending 2023-06-30 was 16.58M CAD, a 69.81% increase year-over-year.
  • Evome Medical Technologies, Inc. revenues for the quarter ending 2023-03-31 was 10.68M CAD, a 23.24% increase year-over-year.
  • Evome Medical Technologies, Inc. revenues for fiscal 2023 was 62.63M CAD.
  • Evome Medical Technologies, Inc. revenues for fiscal 2022 was 18.31M CAD.
  • Evome Medical Technologies, Inc. revenues for fiscal 2021 was -33.55K CAD.
Period endRevenues 0 monthRevenues 0 month as first filedRevenues 1 monthRevenues 1 month as first filedRevenues 3 monthRevenues 6 monthRevenues 9 monthRevenues 10 monthRevenues 12 month
2023-12-3115.72M CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16
35.37M CAD
derived: sum of 2 quarters · filed 2024-04-16
51.94M CAD
derived: sum of 3 quarters · filed 2024-04-16
62.63M CAD
10-K · filed 2024-04-16
2023-09-3019.65M CAD
10-Q · filed 2023-11-14
36.22M CAD
derived: sum of 2 quarters · filed 2023-11-14
46.91M CAD
10-Q · filed 2023-11-14
2023-06-3016.58M CAD
10-Q · filed 2023-08-14
27.26M CAD
10-Q · filed 2023-08-14
2023-05-1564.00M CAD
10-K · filed 2024-04-16
2023-03-3110.68M CAD
10-Q · filed 2023-05-15
2022-12-3133.59M CAD
10-K · filed 2024-04-16
2022-11-3010.55M CAD
10-Q · filed 2023-01-17
30.64M CAD
10-Q · filed 2023-01-17
2022-09-3011.02M CAD
10-Q · filed 2023-11-14
29.45M CAD
10-Q · filed 2023-11-14
2022-09-2337.88M CAD
10-KT · filed 2023-04-03
36.46M CAD
10-Q · filed 2023-01-17
2022-08-3110.04M CAD
10-Q · filed 2022-10-17
20.09M CAD
10-Q · filed 2022-10-17
2022-06-309.76M CAD
10-Q · filed 2023-08-14
18.43M CAD
10-Q · filed 2023-08-14
2022-05-3110.05M CAD
10-Q · filed 2022-07-15
2022-03-318.67M CAD
10-Q · filed 2023-05-15
2022-03-1133.66M CAD
10-KT · filed 2023-04-03
10.11M CAD
10-Q · filed 2022-07-15
2022-02-288.46M CAD
derived: 10-KT 12 month − 10-Q 9 month · filed 2023-04-03
13.75M CAD
derived: sum of 2 quarters · filed 2023-04-03
17.72M CAD
derived: sum of 3 quarters · filed 2023-04-03
18.31M CAD
10-KT · filed 2023-04-03
2021-12-3112.60M CAD
10-KT · filed 2023-04-03
2021-11-305.29M CAD
10-Q · filed 2023-01-17
9.26M CAD
derived: sum of 2 quarters · filed 2023-01-17
9.85M CAD
10-Q · filed 2023-01-17
9.52M CAD
derived: sum of 4 quarters · filed 2023-01-17
2021-08-313.97M CAD
10-Q · filed 2022-10-17
4.56M CAD
10-Q · filed 2022-10-17
4.24M CAD
derived: sum of 3 quarters · filed 2022-10-17
4.46M CAD
derived: sum of 4 quarters · filed 2022-10-17
2021-05-31590.44K CAD
10-Q · filed 2022-07-15
263.48K CAD
derived: sum of 2 quarters · filed 2022-07-15
487.07K CAD
derived: sum of 3 quarters · filed 2022-07-15
565.51K CAD
derived: sum of 4 quarters · filed 2022-07-15
2021-02-28-326.96K CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31
-103.37K CAD
derived: sum of 2 quarters · filed 2022-05-31
-24.93K CAD
derived: sum of 3 quarters · filed 2022-05-31
-33.55K CAD
10-K · filed 2022-05-31
2020-11-30223.59K CAD
10-Q · filed 2022-01-14
302.03K CAD
derived: sum of 2 quarters · filed 2022-01-14
293.41K CAD
10-Q · filed 2022-01-14
2020-08-3178.44K CAD
10-Q · filed 2021-10-15
69.82K CAD
10-Q · filed 2021-10-15
2020-05-31-7.98K CAD
10-Q/A · filed 2021-08-02